# 바이오스페이스 일일 뉴스 리포트 - 2025년 10월 29일


## 주요 헤드라인

1. **Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-ceo-says-trumps-drug-pricing-deals-dont-address-root-problem>

2. **Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-ceo-says-trumps-drug-pricing-deals-dont-address-root-problem>

3. **BMS, Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/bms-cabalettas-car-t-therapy-spurs-remissions-in-small-lupus-trial>

4. **BMS, Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/bms-cabalettas-car-t-therapy-spurs-remissions-in-small-lupus-trial>

5. **BioMarin Abandons Gene Therapy Roctavian, Cuts Revenue Guidance as Voxzogo Faces Competitors (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-abandons-gene-therapy-roctavian-cuts-revenue-guidance-as-voxzogo-faces-competitors>

6. **Biogen Seeks To Stand Out in Lupus With New Anti-CD40L Data (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/biogen-seeks-to-stand-out-in-lupus-with-new-anti-cd40l-data>

7. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/opinion-a-flu-season-in-flux-presents-risks-opportunities-for-biopharma>


---
*2025년 10월 29일 바이오스페이스 뉴스 피드에서 생성된 리포트*